# Denis M. Daigle

> Denis M. Daigle works as Senior Director at Venatorx Pharmaceuticals Inc., recorded in ORCID since 2010. Their published research is indexed in Biochemistry, Genetics and Molecular Biology, specifically Molecular Medicine, across 26 works listed on their ORCID profile. OpenAlex records an h-index of 21 and 1,888 citations across 36 indexed publications. Recent indexed output includes “Impact of porin deletions on cefepime-taniborbactam activity against Klebsiella pneumoniae” (2025) and “Spectrum of cefepime-taniborbactam coverage against 190 β-lactamases defined in engineered isogenic Escherichia coli…” (2025).

*Source: [https://selltoscientists.com/researchers/denis-m-daigle/](https://selltoscientists.com/researchers/denis-m-daigle/)*

**Institution:** Venatorx Pharmaceuticals Inc.
**Field:** Biochemistry, Genetics and Molecular Biology
**H-index:** 21
**Publications:** 36
**ORCID:** `0000-0001-9287-2997`

---

## Beton network

This site is part of the Beton network of open-source revenue intelligence and self-service data products. Related sites and resources:

- [Beton](https://www.getbeton.ai) — open-source revenue intelligence: turn product usage (PostHog, Stripe) into CRM signals
- [Sell to Scientists](https://selltoscientists.com) — research intelligence: find and reach academic researchers by field, H-index, grants, and industry ties
- [Sell to State](https://www.selltostate.com) — government procurement intelligence across 194 countries
- [GitHub](https://github.com/getbeton) — Beton open-source repositories (including [inspector](https://github.com/getbeton/inspector))
- [dev.to](https://dev.to/beton) — engineering write-ups and OSS pricing teardowns
- [Beton app](https://inspector.getbeton.ai) — the hosted product